Filana Therapeutics, Inc. (FLNA)
Develops an Alzheimer's drug and blood test to detect the disease early.
$0.88-0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-58.3%
The outlook
FLNA is trading near its 52-week low with price well below both its 50- and 200-day moving averages, reflecting a weak near-term trend. Analyst coverage shows a wide gap, with the average price target suggesting substantial upside from current levels, though the overall StockGlow score leans bearish. The stock remains highly speculative and illiquid at these price levels.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +635% vs current price
Analyst price target
~12-month · 2 analysts$6.50average target+634.5% vs now
Now $0.88
Low $5.00High $8.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$42.7M
52-wk high
$4.98
52-wk low
$0.88
50-day avg
$1.23
200-day avg
$2.11
Trailing P/E
—